大象传媒

Explore the 大象传媒
This page has been archived and is no longer updated. Find out more about page archiving.

24 September 2014
Press Office
Search the 大象传媒 and Web
Search 大象传媒 Press Office

大象传媒 Homepage

Contact Us

Press Releases

New drug treatments taking 'too long' to approve, say GPs in survey


Category: News; Radio 4

Date: 13.11.2005
Printable version


A survey for 大象传媒 Radio 4's File on 4 programme, carried out by the survey group Medix, shows dissatisfaction among doctors over the time taken to approve new drugs for the NHS in England.

The results favour a faster system of approval such as the one in Scotland.

Of the GPs questioned, 59% say it takes too long for the National Institute for Health and Clinical Excellence, known as NICE, to report on the cost-effectiveness of new treatments.

Only 4% say the time taken is too short.

Concern is even more marked among a group of 62 cancer specialists contacted for the survey - with 51 of them saying the system is 'too slow', none that it's too fast.

The great majority of GPs surveyed, 83%, express support for a more rapid decision process, like the one currently used by the NHS in Scotland which reports within three months of a drug being referred to it.

Using independent analysis of drugs NICE currently averages 14 months.

The Government recently announced a new fast-track through NICE for selected drugs, mainly in the treatment of cancer.

But this will not be a panacea for patients generally, according to Cancer Research UK, since it leaves other drugs, for example for heart disease, stuck in the current time-consuming queue while NICE decides if they should be funded by the NHS.

Gerry Northam's report on the way in which Britain approves new drugs can be heard on File on 4 at 8.00pm on Tuesday 15 November on 大象传媒 Radio 4.

Notes to Editors

If any of the above is used please credit 大象传媒 Radio 4's File on 4.

PRESS RELEASES BY DATE :



PRESS RELEASES BY:

FOLLOW

SEE ALSO:

Category: News; Radio 4

Date: 13.11.2005
Printable version

top^


The 大象传媒 is not responsible for the content of external internet sites



About the 大象传媒 | Help | Terms of Use | Privacy & Cookies Policy